TRICUSPID VALVE REGURGITATION IN PATIENTS UNDERGOING ENDOCARDIAL LEADS PLACEMENT
Objective: To assess prospectively the presence and degree of tricuspid regurgitation (TR) after right ventricular (RV) lead placement utilizing 2-dimensional and doppler echocardiography in a group of patients implanted with Permanent pace-maker or implantable cardioverter defibrillator (ICD). S...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Army Medical College Rawalpindi
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c11811ad31db4e029246ec63814c3fb1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c11811ad31db4e029246ec63814c3fb1 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c11811ad31db4e029246ec63814c3fb12021-12-02T19:12:13ZTRICUSPID VALVE REGURGITATION IN PATIENTS UNDERGOING ENDOCARDIAL LEADS PLACEMENTdoi.org/10.51253/pafmj.v70iSuppl-4.60070030-96482411-8842https://doaj.org/article/c11811ad31db4e029246ec63814c3fb12020-12-01T00:00:00Zhttps://pafmj.org/index.php/PAFMJ/article/view/6007https://doaj.org/toc/0030-9648https://doaj.org/toc/2411-8842Objective: To assess prospectively the presence and degree of tricuspid regurgitation (TR) after right ventricular (RV) lead placement utilizing 2-dimensional and doppler echocardiography in a group of patients implanted with Permanent pace-maker or implantable cardioverter defibrillator (ICD). Study Design: Descriptive cross sectional study. Place and Duration of Study: Study was conducted at OPD of AFIC/NIHD Rawalpindi from Jan to Jun 2019. Methodology: One hundred patients after cardiac stimulation system implantation were included in this study. Patients with severe valve disease, heart failure, congenital heart disease, pre-existing pulmonary hypertension and presence of moderate or severe tricuspid regurgitation were excluded. M-mode, 2 –dimensional and doppler echocardiographic studies were performed. Continuous-wave doppler measurements were made from apical four-chamber view in order to obtain maximum tricuspid flow velocities. A complete echocardiographic study was performed following device implantation. Echocardiographic measurements were repeated at 6-months of follow-up period. Those patients who developed tricuspid regurgitation were further assessed by color doppler, taking into account density and contour of the jet on continuous-wave doppler. Tricuspid regurgitation severity was classified into three groups: mild, moderate and severe according to the recommendations for non-invasive evaluation of native valvular regurgitation by the American Society of Echocardiography. The collected data was analysed by using SPSS-23. Results: Out of 100 patients, 67 (67%) were males and 33(33%) were females with the mean age of 65.29 ± 12.02 years. All the patients had normal chambers dimensions before the procedure. 65 (65%) had leads screwed to RV apex while 35 (35%) had through RV septum. 83 (83%) patients received a dual chamber device, while 17 (17%) patients got single chamber (ventricular) device implanted. Following device implantation after 6 months mild TR was noted in 4 (4%), moderate TR in 4 (4%) and severe TR 2 (2%) in cases. Conclusion: Tricuspid incompetence following endocardial leads implantation is not rare and occurred in approximately 10% of our patients. This complication may be preventable, because it is likely due to the interference of the endocardial lead with the TV.Muhammad AsadQurban Hussain KhanAzmat HayatWaheed -ur- RehmanMuhammad ShabbirAmer NaseemNoor ShahRehana KhadimArmy Medical College Rawalpindiarticlepermanent pacemakertricuspid regurgitationimplantable cardioverter defibrillatorsMedicineRMedicine (General)R5-920ENPakistan Armed Forces Medical Journal, Vol 70, Iss 4, Pp 721-725 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
permanent pacemaker tricuspid regurgitation implantable cardioverter defibrillators Medicine R Medicine (General) R5-920 |
spellingShingle |
permanent pacemaker tricuspid regurgitation implantable cardioverter defibrillators Medicine R Medicine (General) R5-920 Muhammad Asad Qurban Hussain Khan Azmat Hayat Waheed -ur- Rehman Muhammad Shabbir Amer Naseem Noor Shah Rehana Khadim TRICUSPID VALVE REGURGITATION IN PATIENTS UNDERGOING ENDOCARDIAL LEADS PLACEMENT |
description |
Objective: To assess prospectively the presence and degree of tricuspid regurgitation (TR) after right ventricular (RV) lead placement utilizing 2-dimensional and doppler echocardiography in a group of patients implanted with Permanent pace-maker or implantable cardioverter defibrillator (ICD).
Study Design: Descriptive cross sectional study.
Place and Duration of Study: Study was conducted at OPD of AFIC/NIHD Rawalpindi from Jan to Jun 2019.
Methodology: One hundred patients after cardiac stimulation system implantation were included in this study. Patients with severe valve disease, heart failure, congenital heart disease, pre-existing pulmonary hypertension and presence of moderate or severe tricuspid regurgitation were excluded. M-mode, 2 –dimensional and doppler echocardiographic studies were performed. Continuous-wave doppler measurements were made from apical four-chamber view in order to obtain maximum tricuspid flow velocities. A complete echocardiographic study was performed following device implantation. Echocardiographic measurements were repeated at 6-months of follow-up period. Those patients who developed tricuspid regurgitation were further assessed by color doppler, taking into account density and contour of the jet on continuous-wave doppler. Tricuspid regurgitation severity was classified into three groups: mild, moderate and severe according to the recommendations for non-invasive evaluation of native valvular regurgitation by the American Society of Echocardiography. The collected data was analysed by using SPSS-23.
Results: Out of 100 patients, 67 (67%) were males and 33(33%) were females with the mean age of 65.29 ± 12.02 years. All the patients had normal chambers dimensions before the procedure. 65 (65%) had leads screwed to RV apex while 35 (35%) had through RV septum. 83 (83%) patients received a dual chamber device, while 17 (17%) patients got single chamber (ventricular) device implanted. Following device implantation after 6 months mild TR was noted in 4 (4%), moderate TR in 4 (4%) and severe TR 2 (2%) in cases.
Conclusion: Tricuspid incompetence following endocardial leads implantation is not rare and occurred in approximately 10% of our patients. This complication may be preventable, because it is likely due to the interference of the endocardial lead with the TV. |
format |
article |
author |
Muhammad Asad Qurban Hussain Khan Azmat Hayat Waheed -ur- Rehman Muhammad Shabbir Amer Naseem Noor Shah Rehana Khadim |
author_facet |
Muhammad Asad Qurban Hussain Khan Azmat Hayat Waheed -ur- Rehman Muhammad Shabbir Amer Naseem Noor Shah Rehana Khadim |
author_sort |
Muhammad Asad |
title |
TRICUSPID VALVE REGURGITATION IN PATIENTS UNDERGOING ENDOCARDIAL LEADS PLACEMENT |
title_short |
TRICUSPID VALVE REGURGITATION IN PATIENTS UNDERGOING ENDOCARDIAL LEADS PLACEMENT |
title_full |
TRICUSPID VALVE REGURGITATION IN PATIENTS UNDERGOING ENDOCARDIAL LEADS PLACEMENT |
title_fullStr |
TRICUSPID VALVE REGURGITATION IN PATIENTS UNDERGOING ENDOCARDIAL LEADS PLACEMENT |
title_full_unstemmed |
TRICUSPID VALVE REGURGITATION IN PATIENTS UNDERGOING ENDOCARDIAL LEADS PLACEMENT |
title_sort |
tricuspid valve regurgitation in patients undergoing endocardial leads placement |
publisher |
Army Medical College Rawalpindi |
publishDate |
2020 |
url |
https://doaj.org/article/c11811ad31db4e029246ec63814c3fb1 |
work_keys_str_mv |
AT muhammadasad tricuspidvalveregurgitationinpatientsundergoingendocardialleadsplacement AT qurbanhussainkhan tricuspidvalveregurgitationinpatientsundergoingendocardialleadsplacement AT azmathayat tricuspidvalveregurgitationinpatientsundergoingendocardialleadsplacement AT waheedurrehman tricuspidvalveregurgitationinpatientsundergoingendocardialleadsplacement AT muhammadshabbir tricuspidvalveregurgitationinpatientsundergoingendocardialleadsplacement AT amernaseem tricuspidvalveregurgitationinpatientsundergoingendocardialleadsplacement AT noorshah tricuspidvalveregurgitationinpatientsundergoingendocardialleadsplacement AT rehanakhadim tricuspidvalveregurgitationinpatientsundergoingendocardialleadsplacement |
_version_ |
1718377061665472512 |